Primary |
Convulsion |
16.2% |
Headache |
10.3% |
Sleep Disorder |
9.8% |
Neuralgia |
7.4% |
Bipolar Disorder |
6.9% |
Epilepsy |
4.4% |
Insomnia |
4.4% |
Pain |
4.4% |
Anxiety |
3.9% |
Complex Partial Seizures |
3.9% |
Migraine Prophylaxis |
3.9% |
Partial Seizures |
3.4% |
Brain Neoplasm |
2.9% |
Depression |
2.9% |
Generalised Anxiety Disorder |
2.9% |
Post-traumatic Stress Disorder |
2.9% |
Myoclonic Epilepsy |
2.5% |
Obsessive-compulsive Disorder |
2.5% |
Paraesthesia |
2.5% |
Drug Detoxification |
2.0% |
|
Convulsion |
16.9% |
Status Epilepticus |
9.9% |
Tremor |
8.5% |
Off Label Use |
5.6% |
Urinary Incontinence |
5.6% |
Vision Blurred |
5.6% |
Weight Decreased |
5.6% |
Loss Of Consciousness |
4.2% |
Suicidal Ideation |
4.2% |
Tonic Clonic Movements |
4.2% |
Weight Fluctuation |
4.2% |
Complex Partial Seizures |
2.8% |
Grand Mal Convulsion |
2.8% |
Nightmare |
2.8% |
Oral Disorder |
2.8% |
Oscillopsia |
2.8% |
Overdose |
2.8% |
Pneumonia |
2.8% |
Rash |
2.8% |
Respiratory Depression |
2.8% |
|
Secondary |
Sleep Disorder |
15.2% |
Convulsion |
12.6% |
Headache |
8.8% |
Post-traumatic Stress Disorder |
8.5% |
Drug Use For Unknown Indication |
8.2% |
Neuralgia |
6.5% |
Agoraphobia |
4.9% |
Epilepsy |
4.9% |
Panic Attack |
4.9% |
Anxiety |
4.4% |
Pain |
3.6% |
Insomnia |
3.3% |
Migraine Prophylaxis |
3.3% |
Bipolar Disorder |
2.0% |
Brain Neoplasm |
2.0% |
Obsessive-compulsive Disorder |
2.0% |
Hypertension |
1.6% |
Depression |
1.3% |
Complex Partial Seizures |
1.1% |
Fibromyalgia |
1.1% |
|
Tremor |
12.6% |
Urinary Incontinence |
12.6% |
Pneumonia |
8.1% |
Tongue Paralysis |
7.2% |
Weight Decreased |
7.2% |
Convulsion |
5.4% |
Somnolence |
5.4% |
Blood Alkaline Phosphatase Increased |
4.5% |
Vomiting |
4.5% |
Speech Disorder |
3.6% |
Vertigo |
3.6% |
Weight Increased |
3.6% |
Oral Disorder |
2.7% |
Respiratory Arrest |
2.7% |
Skin Laceration |
2.7% |
Suicide Attempt |
2.7% |
Swelling Face |
2.7% |
Tonic Clonic Movements |
2.7% |
Unresponsive To Verbal Stimuli |
2.7% |
Wound |
2.7% |
|
Concomitant |
Drug Use For Unknown Indication |
14.3% |
Product Used For Unknown Indication |
12.4% |
Depression |
9.7% |
Pain |
9.2% |
Anxiety |
7.8% |
Bipolar Disorder |
6.9% |
Sleep Disorder |
5.3% |
Convulsion |
4.7% |
Nuclear Magnetic Resonance Imaging |
3.9% |
Hypertension |
3.0% |
Epilepsy |
2.8% |
Insomnia |
2.8% |
Angiogram |
2.7% |
Back Pain |
2.6% |
Post Laminectomy Syndrome |
2.5% |
Post-traumatic Stress Disorder |
2.1% |
Neuralgia |
2.0% |
Affective Disorder |
1.8% |
Diabetes Mellitus |
1.8% |
Multiple Sclerosis |
1.8% |
|
Weight Increased |
15.0% |
Type 2 Diabetes Mellitus |
13.6% |
Tremor |
10.3% |
Weight Decreased |
7.5% |
Suicide Attempt |
6.6% |
Skin Tightness |
5.2% |
Respiratory Failure |
3.8% |
Vomiting |
3.8% |
Serotonin Syndrome |
3.3% |
Suicidal Ideation |
3.3% |
Tooth Loss |
3.3% |
Toothache |
3.3% |
Withdrawal Syndrome |
3.3% |
Pneumonia |
2.8% |
Wound Secretion |
2.8% |
Wrong Technique In Drug Usage Process |
2.8% |
Myocardial Infarction |
2.3% |
Rash |
2.3% |
Somnolence |
2.3% |
Visual Acuity Reduced |
2.3% |
|
Interacting |
Epilepsy |
26.4% |
Bipolar Disorder |
17.0% |
Parkinson's Disease |
15.1% |
Anxiety |
7.5% |
Nightmare |
7.5% |
Convulsion |
5.7% |
Ill-defined Disorder |
3.8% |
Insomnia |
3.8% |
Psychogenic Pain Disorder |
3.8% |
Temporal Lobe Epilepsy |
3.8% |
Candidiasis |
1.9% |
Pain |
1.9% |
Prophylaxis |
1.9% |
|
Drug Interaction |
36.4% |
Chromatopsia |
18.2% |
Tremor |
18.2% |
Vitreous Floaters |
18.2% |
Weight Decreased |
9.1% |
|